Drug | Class (action) |
Definitely associated with ovarian damage | |
Nitrogen mustard | Mechlorethamine (alkylating agent) |
L-phenylalanine mustard | Mechlorethamine (alkylating agent) |
Chlorambucil | Chloroethylamine (alkylating agent) |
Cyclophosphamide | Chloroethylamine (alkylating agent) |
Melphalan | Mechlorethamine (alkylating agent) |
Busulfan | Alkylalkane sulfonate (alkylating agent) |
Procarbazine | Substituted hydrazine |
Dacarbazine | Alkylating agent |
Doxorubicin | Anthracycline |
Probably associated with ovarian damage | |
Cis-platinum | Heavy metal |
Carmustine | Nitrosourea (alkylating agent) |
Lomustine | Nitrosourea (alkylating agent) |
Daunorubicin | Anthracycline |
Low probability of ovarian damage | |
Methotrexate | Antimetabolite |
Fluorouracil (5-FU) | Antimetabolite |
6-mercaptopurine | Antimetabolite |
Vincristine | Vinca alkaloid |
Mitomycin | Antibiotic (alkylating agent) |
Bleomycin | Peptide |
Vinblastine | Vinca alkaloid |
Cytosine arabinoside (Ara-C) | Antimetabolite |
VP-16 (etoposide) | Podophyllotoxin |
Imatinib | Tyrosine kinase inhibitor |
Unknown | |
VM-26 | Podophyllotoxin |
Vindesine | Vinca alkaloid |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟